There are few endeavors that are more rewarding than the training of young scientists who aspire to the highest levels of their profession. Over the years, I have devoted my energies to training undergraduate, graduate, and post-doctoral associates to become highly respected neuroscientists, neuropharmacologists, or neurobehavioral scientists. Twenty graduate students have received their PhD training under my tutelage, 10 have received their Masters degree, and 17 have received Post-Doctoral training in my laboratory. Their careers reflect their dedication to science and to life-long achievements. Some, including those who were trained as undergraduate students, are professors at various universities in the United States or other countries, some are leaders of laboratories at the National Institutes of Health or other research institutions, some are in the pharmaceutical or biotechnology industry, and some are in the legal or business professions as biomedical experts.
The training that I can give to students and post-doctoral associates comes from many years of experience and productivity in areas of the neurological and other biomedical sciences. My training as both an MD and a PhD scientist has allowed me to conduct a wide variety of research into important biomedical problems, such as alcohol abuse and related brain damage, seizure neurobiology, and aging-associated neurodegeneration. I also bring a good understanding of pathways to success for my students and post-doctoral associates because of my own experiences. During my PhD training at the University of Kentucky Medical Center I received a Special Fellowship awarded by the National Institutes on Neurological Diseases and Stroke, during the early stages of my scientific career I received a MERIT award from the National Institute on Alcoholism and Alcohol Abuse. Later on, I received the Higuchi Award for Biomedical Sciences at the University of Kansas and the Distinguished Alumnus Award from St. Louis University School of Medicine, and was named a University of Kansas Distinguished Professor. The research programs in my laboratory have been supported continuously through funding from the National Institutes of Health, the National Science Foundation, the Department of Defense, the American Heart Association, and private foundations and pharmaceutical companies. I have served on the Scientific Advisory Boards of the Oread Laboratories pharmaceutical, Promega biotechnology, and Aventis pharmaceutical companies, as well as many NIH review panels, and this service has allowed me to further the careers of my associates.